Increase in elderly population and rise in cases of chronic diseases are fueling growth of Peptide Therapeutics Market

Peptide therapeutics are a type of drug that uses short chains of amino acids (peptides) to target specific biological pathways in the body. Peptides are smaller than proteins and are made up of amino acids that are linked together by peptide bonds.

Peptide therapeutics can be designed to mimic natural peptides that are already present in the body, or they can be engineered to have specific properties, such as increased stability or improved binding to their target.

Request Report Sample - https://www.alliedmarketresearch.com/request-sample/11591

Peptide therapeutics are used to treat a wide range of conditions, including cancer, diabetes, autoimmune diseases, and infectious diseases. Some examples of peptide therapeutics include insulin, which is used to treat diabetes, and liraglutide, which is used to treat obesity.

The peptide therapeutics market was valued at $33.3 billion in 2021, and is estimated to reach $64.3 billion by 2031, growing at a CAGR of 6.8% from 2022 to 2031.

Procure Complete Report (309 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/68c60bad716afcb0359c65cd67e2a50d

The peptide therapeutics market has been steadily growing in recent years and is expected to continue to do so in the future.

The growth of the peptide therapeutics market can be attributed to several factors. One of the main drivers is the increasing prevalence of chronic diseases such as cancer and diabetes, which require long-term treatment with targeted therapies.

Peptide therapeutics are well-suited for these types of treatments because they can be designed to target specific biological pathways and have fewer side effects than other types of drugs.

Speak to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/11591

Key findings of the study

• By application, the metabolic segment was the highest contributor to the peptide therapeutics industry in 2021.
• By route of administration, the parenteral segment was the highest contributor to the peptide therapeutics industry in 2021.
• Depending on distribution channel, the hospital pharmacies segment was highest contributor in 2021, and is expected to continue this trend during the forecast period.
• Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Read More- https://www.alliedmarketresearch.com/peptide-therapeutics-market-A11226

Related Reports-

Microwave Ablation Systems Market - https://www.alliedmarketresearch.com/microwave-ablation-systems-market

Medical Crutches Market - https://www.alliedmarketresearch.com/medical-crutches-market

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.